Screener
Crinetics Pharmaceuticals CRNX Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Crinetics Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001658247-26-000040
FAQ
- What is Crinetics Pharmaceuticals's asset turnover?
- Crinetics Pharmaceuticals (CRNX) reported asset turnover of 0× in Q1 2026.
- How has Crinetics Pharmaceuticals's asset turnover changed year-over-year?
- Crinetics Pharmaceuticals's asset turnover increased by 2083.3% year-over-year, from 0× to 0×.
- What is the long-term trend for Crinetics Pharmaceuticals's asset turnover?
- Over 4 years (2021 to 2025), Crinetics Pharmaceuticals's asset turnover has grown at a 10.7% compound annual growth rate (CAGR), from 0× to 0×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Crinetics Pharmaceuticals's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude